BMJ Open, 2018 · DOI: 10.1136/bmjopen-2018-023785 · Published: September 26, 2018
This study aims to quantify the acute care costs for patients with TSCI across NSW, exploring health service pathway and clinical practice variations potentially attributable to higher cost hospitalizations. The study also intends to describe the incidence of potentially preventable complications in patients with acute TSCI and the associated incremental healthcare costs. Finally, it aims to benchmark actual patient pathways and care against best practice standards, quantifying financial costs associated with deviation of care from these standards.
Understanding the costs and health service drivers associated with potentially preventable complications should clarify the investment potential in the construction and implementation of a cost-effective ‘best-practice’ clinical pathway for patients with TSCI.
The study is ideally placed to establish standards, and reduce costs with potential for research translation across the state of NSW.
These findings are likely to have significant clinical consequences for the patient, cost implications for the health service and offer significant potential to make amenable recommendations for improvement.